Recall rate and positive predictive value of MSUD screening is not influenced by hydroxyproline
- 6 August 2008
- journal article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 168 (5) , 599-604
Abstract
Maple syrup urine disease (MSUD) is an autosomal recessive inherited disorder caused by the deficiency of the branched-chain 2-oxo acid dehydrogenase (BCOA-DH) complex. The worldwide incidence is approximately 1 in 185,000. MSUD is integrated in many “expanded” newborn screening (NBS) programs that use electrospray ionization tandem mass spectrometry (ESI-MS/MS). Elevated leucine, isoleucine, and alloisoleucine in the dried blood samples (DBS) of newborns are diagnostic parameters. However, with the applied method, it is not possible to distinguish the amino acids from each other, and also not from the other isobaric amino acid, hydroxyproline. While the branched chain amino acids (BCAA) leucine, isoleucine, and alloisoleucine are no diagnostic problem, because they are all elevated in MSUD patients, and, rather, increase the diagnostic sensitivity and specificity, hydroxyproline may cause false-positive screening results. Hydroxyproline is elevated in the benign familial condition hyperhydroxyprolinemia, which needs no medical intervention. The detection of cases with hyperhydroxyprolinemia have formerly been reported from screening programs that used thin-layer chromatography for phenylketonuria (PKU) screening, and, recently, two more cases have been reported, detected by ESI-MS/MS-based NBS. However, the detection of non-diseases is a heavy burden for screening programs and should be avoided if possible. With optimal settings for the quantitation of BCAAs and interpretation rules, elevated hydroxyproline should not cause false-positive screening results.Keywords
This publication has 14 references indexed in Scilit:
- Maple Syrup Urine Disease: Newborn Screening Fails to Discriminate between Classic and Variant FormsClinical Chemistry, 2008
- Second-Tier Test for Quantification of Alloisoleucine and Branched-Chain Amino Acids in Dried Blood Spots to Improve Newborn Screening for Maple Syrup Urine Disease (MSUD)Clinical Chemistry, 2008
- Variant maple syrup urine disease (MSUD)—The entire spectrumJournal of Inherited Metabolic Disease, 2006
- Maple syrup urine disease: Favourable effect of early diagnosis by newborn screening on the neonatal course of the diseaseJournal of Inherited Metabolic Disease, 2006
- Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity ofMCCA andMCCB mutations and impact on risk assessmentHuman Mutation, 2006
- Hyperhydroxyprolinaemia: a new case diagnosed during neonatal screening with tandem mass spectrometryRapid Communications in Mass Spectrometry, 2005
- Hyperhydroxyprolinaemia detected in newborn screening with tandem mass spectrometryJournal of Inherited Metabolic Disease, 2004
- Hydroxyprolinemia: Comparison of a patient and her unaffected twin sisterThe Journal of Pediatrics, 1997
- Hydroxyprolinemia as an Illustration of Nonessential Enzymes in ManNew England Journal of Medicine, 1970
- Hydroxyprolinemia* an Apparently Harmless Familial Metabolic DisorderNew England Journal of Medicine, 1970